Page 71 - MI-2-3

Microbes & Immunity Natural phage patentability in the U.S.

(Cont’d...)

AU Record

EP Record EP1663302B1

Certain phage (s) ATCC No. PTA-7948 ATCC No. PTA-5372, PTA-5373, PTA-5374, PTA-5375, PTA-5376, and PTA-5377 ATCC No. PTA-8358, PTA-8359, PTA-8360, PTA-8361, PTA-8362, PTA-8363, and PTA-8364 ATCC No. PTA-9479, PTA-8479, and PTA-8480 ATCC No. PTA-8481, and PTA-8483 ATCC No. PTA-5280, PTA-5281, PTA-5282, PTA-5283, PTA-5284, and PTA-5285 ATCC No. PTA-8347, PTA-8348, PTA-8351, and PTA-8352 ATCC No

Sequence similarity threshold NA NA NA NA NA NA NA NA

Main claim (s) A natural phage Natural phage compositions Natural phage compositions Natural phage compositions Natural phage compositions Natural phage compositions Natural phage compositions and a method of its use in food Natural phage compositions and a method of its use in food

Target E. coli Listeria P. aeruginosa C. perfringens C. perfringens Salmonella E. coli E. coli

O157: H7 bacteriophage and uses thereof Listeria monocytogenes bacteriophages and uses bacteriophage and uses bacteriophage and uses bacteriophage and uses Salmonella bacteriophage and uses thereof E. coli bacteriophage and E. coli O157: H7 bacteriophage and uses
Table 1. Representative granted patents in phage therapy in the US

Title thereof P. aeruginosa: thereof C. perfringens thereof C. perfringens thereof uses thereof thereof

Assignee Intralytix Intralytix Intralytix Intralytix Intralytix Intralytix Intralytix Intralytix

Issue date (month/ day/year) December 22, 2009 March 24, 2009 November 24, 2009 December 1, 2009 December 1, 2009 March 9, 2010 December 1, 2009 December 1, 2009

US Patent number 7635584-B2 7507571-B2 7622293-B2 7625739-B2 7625740-B2 7674467-B2 7625556-B2 7625741-B2

Volume 2 Issue 3 (2025) 63 doi: 10.36922/mi.4758